Counseling Needed for Pediatric Patients With Impaired Fertility

Share this content:
Counseling Needed for Pediatric Patients With Impaired Fertility
Counseling Needed for Pediatric Patients With Impaired Fertility

THURSDAY, Aug. 16, 2018 (HealthDay News) -- Counseling about impaired fertility and sexual function for at-risk pediatric populations in developmentally appropriate ways is essential, according to a clinical report published in the August issue of Pediatrics.

Leena Nahata, M.D., from The Ohio State University in Columbus, and colleagues reviewed evidence and considerations for providers related to information sharing about impaired fertility and sexual function in pediatric patients attributable to congenital and acquired conditions or treatments.

The American Academy of Pediatrics recommends that providers assess risk, use an interdisciplinary team approach, and assess what the family knows, as well as what interventions have already been performed. Clinicians should also consider cultural factors, ethical issues, and other special circumstances that may impact communication in planning initial talking points for both the parents and patient on the basis of age or developmental stage. Recommended counseling considerations include allowing sufficient time; normalizing the stress of ambiguity, and acknowledging family stressors.

"Given that numerous pediatric conditions and treatments impair reproductive capacity and sexual function, general pediatricians and pediatric medical subspecialists should provide ongoing counseling about these risks and potential management options as well as psychosocial support," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »